Personalis, Inc. Common Stock
Symbol: PSNL (NASDAQ)
6.08
▲ (12.71%) 0.685
Company Description:
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Key Stats
- Today's Open: $5.39
- Today's High: $6.245
- Today's Low: $5.382
- Today's Volume: 1.52M
- Yesterday Close: $5.39
- Yesterday High: $5.565
- Yesterday Low: $5.32
- Yesterday Volume: 936.18K
- Last Min Volume: 5
- Last Min High: $6.075
- Last Min Low: $6.075
- Last Min VWAP: $6.075
Company Profile
- Name: Personalis, Inc. Common Stock
- Website: https://www.personalis.com
- Listed Date: 2019-06-20
- Location: FREMONT, CA
- Market Status: Active
- CIK Number: 0001527753
- SIC Code: 8071
- SIC description: SERVICES-MEDICAL LABORATORIES
- Market Cap: $477.97M
- Round Lot: 100
- Outstanding Shares: 88.68M
- Asset Type: CS
RECENT FILINGS FOR PSNL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-22 | 8-K | View |
| 2025-08-05 | S-8 | View |
| 2025-08-05 | 8-K | View |
| 2025-08-05 | 10-Q | View |
| 2025-07-30 | 4 | View |
| 2025-07-30 | 4 | View |
| 2025-07-09 | 8-K | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-19 | 8-K | View |
| 2025-05-14 | SCHEDULE 13G/A | View |
| 2025-05-06 | 10-Q | View |
| 2025-05-06 | 8-K | View |
Latest News on PSNL